Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer.

Details

Language :

English

ISSN :

0732183X

Volume :

33

Issue :

33

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

110916453

Full Text :

https://doi.org/10.1200/JCO.2014.60.0320